You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Low Control Voltage, Thin Film Multiferroic Tunable Devices for RF Applications
SBC: QUINSTAR TECHNOLOGY, INCORPORATED Topic: ST13B003We propose a novel suspended multiferroic thin film structure fabricated by semiconductor processing technologies as the basis for the approach to designing the multiferroic microstrip-based circuit elements such as tunable filters. The proposed approach
STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency -
A High-Level Operator Abstraction for GPU Graph Analytics
SBC: Royal Caliber Topic: ST13B004We propose to build a framework around an operator formulation to enable rapid development of massively parallel solutions to large graph problems. Graph algorithms are expressed by a small number of operators that are applied to components of the graph.
STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency -
Data-Parallel Analytics on Graphics Processing Units (GPUs)
SBC: SYSTAP, LLC Topic: ST13B004The proposed effort will extend existing proofs of concept and advanced research systems to: (a) provide an efficient, low-level, data-parallel runtime for graph processing on GPUs; (b) provide a high-level abstraction for writing graph analytics that are
STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency -
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cyto
SBC: Nirvana Sciences, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): Polychromatic flow cytometry [FC] is one of the most powerful analytical techniques routinely used in immunology. Flow cytometry plays a critical role in several growing clinical applications: leukemia and lymphoma immunophenotyping for diagnosis and sub-categorization (now using 8-10 colors); in CD4/CD8 measurement in HIV-positive patients; and in HLA typing f ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Novel Small Molecule Therapeutics for Pancreatic Cancer
SBC: ChemRegen Inc Topic: NCIProject Summary/Abstract Developing new ways to treat pancreatic cancer is a significant challenge. Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and results in an estimated 37,000 deaths/year. Pancreatic cancer therapeutic options are limited to surgery and/or combinations of chemotherapy and radiation. Unfortunately, late-stage diagnosis of pancreat ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
ChemoFilter: A Novel Catheter Device to Enable High-Dose Chemotherapy Treatment
SBC: CHEMOFILTER, INC. Topic: NCIProject Summary: Intravenous dosing of drugs for applications ranging from cancer chemotherapy to anti-microbials to lytic (blood clot dissolving) agents is limited by systemic toxicity. Currently, the only ways to remove drugs from the blood are throughnatural metabolism or costly impractical measures such as dialysis. Despite intense focus on targeted drug delivery agents, these therapies are c ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Developing Novel Therapies for Treating Breast-Cancer-Related Lymphedema
SBC: ADEPTHERA, LLC Topic: NCIDESCRIPTION (provided by applicant): Destruction of lymphatic vessels during the treatment of breast cancer by surgery and/or radiation therapy can lead to the development of secondary lymphedema. The breast-cancer-related lymphedema is associated with debilitating limb swelling, chronic inflammation, tissue fibrosis, and increased susceptibility to infection. It has been estimated that approximat ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Intra-procedure Deformable Ultrasound-MRI Fusion for Prostate Biopsies
SBC: ZMK Medical Technologies, Inc. Topic: NCIThis proposal is a collaborative effort between Yale University and the medical device company Eigen to develop a more robust and accurate method for the deformable fusion of pre-operative magnetic resonance images (MRI) and intra-procedure trans-rectal ultrasound (TRUS) images to guide prostate biopsy. Prostate cancer is a major cause of death in the U.S. and biopsy is the gold-standard for its d ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Validation of a Novel Treatment for Glioblastoma
SBC: CURTANA PHARMACEUTICALS INC Topic: NCI? DESCRIPTION (provided by applicant): The goal of this application is to study in vivo efficacy of CT102, a newly discovered inhibitor of the OLIG2 transcription factor in animal models of glioblastoma (GBM), a highly underserved area of pharmacotherapy. In this proposal, the experienced drug discovery group at Curtana Pharmaceuticals Inc. will conduct a pre-clinical evaluation of selectivity ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Targeting of Myc-Max dimerization for the treatment of cancer
SBC: SORRENTO THERAPEUTICS, INC. Topic: NCIDESCRIPTION (provided by applicant): Myc is a key transcriptional regulator due to its critical role in many fundamental cellular processes, such as cell cycle progression and cell growth. Therefore, dysregulation of Myc expression can lead to disease, including cancer. Myc is overexpressed in many human tumors, and it is estimated that 1 in 7 cancer deaths in the United States are resultant of hi ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health